JP2018524977A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018524977A5 JP2018524977A5 JP2017564424A JP2017564424A JP2018524977A5 JP 2018524977 A5 JP2018524977 A5 JP 2018524977A5 JP 2017564424 A JP2017564424 A JP 2017564424A JP 2017564424 A JP2017564424 A JP 2017564424A JP 2018524977 A5 JP2018524977 A5 JP 2018524977A5
- Authority
- JP
- Japan
- Prior art keywords
- adenovirus
- protein
- acid sequence
- seq
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1510357.5A GB201510357D0 (en) | 2015-06-12 | 2015-06-12 | Adenovirus polynucleotides and polypeptides |
| EPPCT/EP2015/063248 | 2015-06-12 | ||
| PCT/EP2015/063248 WO2015189425A1 (en) | 2014-06-13 | 2015-06-12 | Immunogenic combinations |
| GB1510357.5 | 2015-06-12 | ||
| GBGB1514772.1A GB201514772D0 (en) | 2015-08-19 | 2015-08-19 | Adenovirus polynucleotides and polypeptides |
| GB1514772.1 | 2015-08-19 | ||
| PCT/EP2016/063297 WO2016198599A1 (en) | 2015-06-12 | 2016-06-10 | Adenovirus polynucleotides and polypeptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018524977A JP2018524977A (ja) | 2018-09-06 |
| JP2018524977A5 true JP2018524977A5 (enExample) | 2019-07-11 |
| JP6983665B2 JP6983665B2 (ja) | 2021-12-17 |
Family
ID=57503533
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017564424A Expired - Fee Related JP6983665B2 (ja) | 2015-06-12 | 2016-06-10 | アデノウイルスポリヌクレオチド及びポリペプチド |
| JP2017564467A Active JP6873054B2 (ja) | 2015-06-12 | 2016-06-10 | アデノウイルスポリヌクレオチド及びポリペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017564467A Active JP6873054B2 (ja) | 2015-06-12 | 2016-06-10 | アデノウイルスポリヌクレオチド及びポリペプチド |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US11254710B2 (enExample) |
| EP (2) | EP3307313A1 (enExample) |
| JP (2) | JP6983665B2 (enExample) |
| KR (2) | KR20180012857A (enExample) |
| CN (2) | CN108025058B (enExample) |
| AU (4) | AU2016275601A1 (enExample) |
| BE (1) | BE1024420B1 (enExample) |
| BR (1) | BR112017026523A2 (enExample) |
| CA (1) | CA2988654A1 (enExample) |
| EA (1) | EA038402B9 (enExample) |
| IL (2) | IL256069B2 (enExample) |
| MX (2) | MX2017016101A (enExample) |
| WO (2) | WO2016198621A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112017026523A2 (pt) | 2015-06-12 | 2018-08-14 | Glaxosmithkline Biologicals Sa | vetor recombinante, adenovírus recombinante, composição, uso de um vetor recombinante, de um adenovírus recombinante ou de uma composição, método para induzir uma resposta imune em um indivíduo, e, polinucleotídeo isolado. |
| GB201513176D0 (en) | 2015-07-27 | 2015-09-09 | Glaxosmithkline Biolog Sa | Novel methods for inducing an immune response |
| GB201620968D0 (en) | 2016-12-09 | 2017-01-25 | Glaxosmithkline Biologicals Sa | Adenovirus polynucleotides and polypeptides |
| ES2959811T3 (es) * | 2016-12-09 | 2024-02-28 | Glaxosmithkline Biologicals Sa | Construcciones de adenovirus de chimpancé con antígenos de Lyssavirus |
| WO2019016756A1 (en) | 2017-07-21 | 2019-01-24 | Glaxosmithkline Biologicals Sa | ANTIGEN CONSTRUCTS OF CHIKUNGUNYA VIRUSES |
| EP3697902A1 (en) | 2017-10-16 | 2020-08-26 | GlaxoSmithKline Biologicals S.A. | Enhanced promoter |
| JP2021500880A (ja) | 2017-10-16 | 2021-01-14 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ２つの発現カセットを有するサルアデノウイルスベクター |
| WO2019076877A1 (en) | 2017-10-16 | 2019-04-25 | Glaxosmithkline Biologicals Sa | ADENOVIRAL VECTORS FOR REPLICATION |
| EP3697919A1 (en) | 2017-10-16 | 2020-08-26 | GlaxoSmithKline Biologicals SA | Adenoviral vectors with two expression cassettes encoding rsv antigenic proteins or fragments thereof |
| WO2019086466A1 (en) * | 2017-10-31 | 2019-05-09 | Janssen Vaccines & Prevention B.V. | Adenovirus and uses thereof |
| GB201721069D0 (en) | 2017-12-15 | 2018-01-31 | Glaxosmithkline Biologicals Sa | Hepatitis B Immunisation regimen and compositions |
| GB201721068D0 (en) | 2017-12-15 | 2018-01-31 | Glaxosmithkline Biologicals Sa | Hepatitis B immunisation regimen and compositions |
| BR112020012361A2 (pt) * | 2017-12-20 | 2020-11-24 | Glaxosmithkline Biologicals S.A. | constructos de antígeno do vírus epstein-barr |
| EP3807298A1 (en) | 2018-06-12 | 2021-04-21 | GlaxoSmithKline Biologicals S.A. | Adenovirus polynucleotides and polypeptides |
| US20210277417A1 (en) * | 2018-06-25 | 2021-09-09 | Akouos, Inc. | Methods of treating clrn1-associated hearing loss and/or vision loss |
| EP3587581A1 (en) | 2018-06-26 | 2020-01-01 | GlaxoSmithKline Biologicals S.A. | Formulations for simian adenoviral vectors having enhanced storage stability |
| EP3810277A1 (en) * | 2018-07-20 | 2021-04-28 | Janssen Vaccines & Prevention B.V. | Recombinant adenoviral vector expressing zika antigen with improved productivity |
| EP3833382A1 (en) | 2018-08-07 | 2021-06-16 | GlaxoSmithKline Biologicals S.A. | Processes and vaccines |
| EP3897846A1 (en) | 2018-12-21 | 2021-10-27 | GlaxoSmithKline Biologicals SA | Methods of inducing an immune response |
| CA3132601A1 (en) | 2019-03-05 | 2020-09-10 | Glaxosmithkline Biologicals Sa | Hepatitis b immunisation regimen and compositions |
| EP4150344A1 (en) | 2020-05-14 | 2023-03-22 | GlaxoSmithKline Biologicals SA | Viral biosensors |
| CN121816424A (zh) * | 2023-08-11 | 2026-04-07 | 拜奥卡德联合股份公司 | 用于生产基于腺相关病毒(AAV)的载体(变体)的腺病毒E2a基因的修饰的序列 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8919102D0 (en) * | 1989-08-22 | 1989-10-04 | Oxford Virology Ltd | A recombinant adenovirus dna sequence,a recombinant adenovirus expressing the dna sequence and a rhabdovirus vaccine including the recombinant adenovirus |
| KR20040043129A (ko) | 2001-06-22 | 2004-05-22 | 더 위스타 인스티튜트 오브 아나토미 앤드 바이올로지 | 세포독성 면역 반응을 유도하는 방법과 그에 유용한재조합체 원숭이 아데노바이러스 조성물 |
| AU2002365366B2 (en) * | 2001-11-21 | 2007-05-10 | The Trustees Of The University Of Pennsylvania | Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| US7030094B2 (en) | 2002-02-04 | 2006-04-18 | Corixa Corporation | Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21 |
| US7960522B2 (en) | 2003-01-06 | 2011-06-14 | Corixa Corporation | Certain aminoalkyl glucosaminide phosphate compounds and their use |
| US7205342B2 (en) * | 2003-10-10 | 2007-04-17 | General Electric Company | Poly(arylene ether) composition and method of molding |
| DE602005017743D1 (de) * | 2004-01-23 | 2009-12-31 | Angeletti P Ist Richerche Bio | Impfstoffträger für schimpansen-adenovirus |
| EP2848692B1 (en) | 2004-05-21 | 2017-08-16 | Novartis Vaccines and Diagnostics, Inc. | Alphavirus vectors for influenza virus vaccines |
| CN102220357B (zh) * | 2004-11-16 | 2013-12-25 | 克鲁塞尔荷兰公司 | 包含重组病毒载体的多价疫苗 |
| AR053275A1 (es) * | 2005-05-12 | 2007-04-25 | Glaxo Group Ltd | Composicion de vacuna |
| WO2006133911A2 (en) * | 2005-06-17 | 2006-12-21 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Hepatitis c virus nucleic acid vaccine |
| PL2137210T3 (pl) * | 2007-03-02 | 2017-06-30 | Glaxosmithkline Biologicals Sa | Nowy sposób i kompozycje |
| GB0706914D0 (en) * | 2007-04-10 | 2007-05-16 | Isis Innovation | Novel adenovirus vectors |
| AU2008331905B2 (en) * | 2007-11-28 | 2014-09-18 | The Trustees Of The University Of Pennsylvania | Simian subfamily B adenovirus SAdV-28 and uses thereof |
| CN102131920B (zh) * | 2007-11-28 | 2013-11-06 | 宾夕法尼亚大学托管会 | 猿猴亚家族C腺病毒SAdV-40、-31和-34及其应用 |
| CN101883858B (zh) * | 2007-11-28 | 2015-07-22 | 宾夕法尼亚大学托管会 | 猿猴亚家族E腺病毒SAdV-39、-25.2、-26、-30、-37和-38及其应用 |
| JP5661476B2 (ja) * | 2008-03-04 | 2015-01-28 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | サルアデノウイルスＳＡｄＶ−３６、−４２．１、−４２．２および−４４ならびにそれらの用途 |
| WO2009146902A1 (en) * | 2008-06-03 | 2009-12-10 | Okairòs Ag | A vaccine for the prevention and therapy of hcv infections |
| WO2010085984A1 (en) * | 2009-02-02 | 2010-08-05 | Okairos Ag | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| PL2391638T3 (pl) * | 2009-02-02 | 2018-11-30 | Glaxosmithkline Biologicals Sa | Sekwencje nukleotydowe i aminokwasowe małpiego adenowirusa, zawierające je wektory i ich zastosowania |
| CA2762203A1 (en) * | 2009-05-29 | 2010-12-02 | Soumitra Roy | Simian adenovirus 41 and uses thereof |
| JP5903045B2 (ja) * | 2009-07-31 | 2016-04-13 | パックスバックス， インコーポレイテッド | アデノウイルスに基づくベクター |
| US9526777B2 (en) * | 2010-04-16 | 2016-12-27 | The United States Of America As Represented By The Department Of Health And Human Services | Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein |
| CA2798739A1 (en) | 2010-05-26 | 2011-12-01 | Selecta Biosciences, Inc. | Nanocarrier compositions with uncoupled adjuvant |
| GB201016471D0 (en) * | 2010-09-30 | 2010-11-17 | Isis Innovation | Viral vector immunogenic compositions |
| US20120328605A1 (en) | 2010-10-27 | 2012-12-27 | Daniel Larocque | Compositions and uses |
| WO2012089231A1 (en) | 2010-12-30 | 2012-07-05 | Okairòs Ag | Paramyxovirus vaccines |
| GB201108879D0 (en) * | 2011-05-25 | 2011-07-06 | Isis Innovation | Vector |
| CA2841047A1 (en) * | 2011-07-06 | 2013-01-10 | Novartis Ag | Immunogenic compositions and uses thereof |
| FR2978457A1 (fr) * | 2011-07-27 | 2013-02-01 | Univ Paris Diderot Paris 7 | Composes contenant un vecteur viral a specificite hepatique et presentant une activite anti-inflammatoire |
| US9233153B2 (en) * | 2011-10-05 | 2016-01-12 | Genvec, Inc. | Affenadenovirus (gorilla) or adenoviral vectors and methods of use |
| CN103239734B (zh) * | 2012-02-10 | 2016-02-24 | 北京艾棣维欣生物技术有限公司 | 用于预防和/或治疗呼吸道合胞病毒感染的疫苗 |
| JP5805908B2 (ja) | 2012-03-22 | 2015-11-10 | クルセル ホランド ベー ヴェー | Ｒｓｖに対するワクチン |
| KR102435054B1 (ko) | 2012-08-01 | 2022-08-22 | 버베리안 노딕 에이/에스 | 재조합 변형된 백시니아 바이러스 앙카라(ankara) (mva) 호흡기 신시티알 바이러스(rsv) 백신 |
| EP2922570A1 (en) | 2012-11-20 | 2015-09-30 | GlaxoSmithKline Biologicals SA | Rsv f prefusion trimers |
| DE102012221236A1 (de) | 2012-11-21 | 2014-05-22 | Zf Friedrichshafen Ag | Getriebe |
| GB201303406D0 (en) * | 2013-02-26 | 2013-04-10 | Health Prot Agency | Crimean-Congo Haemorrhagic Fever Virus Antigenic Composition |
| MX370573B (es) | 2013-04-18 | 2019-12-17 | Immune Design Corp | Monoterapia con glucopiranosil lipido a para usarse en el tratamiento del cancer. |
| CN103937835A (zh) * | 2013-08-19 | 2014-07-23 | 中国科学院上海巴斯德研究所 | 一种基于腺病毒AdC68的表达载体及其构建方法 |
| CN103923943B (zh) * | 2013-08-19 | 2019-01-22 | 中国科学院上海巴斯德研究所 | 一种基于腺病毒AdC7的表达载体及其构建方法 |
| GB201318084D0 (en) * | 2013-10-11 | 2013-11-27 | Isis Innovation | Malaria vaccination |
| MX384992B (es) | 2014-06-13 | 2025-03-14 | Glaxosmithkline Biologicals Sa | Combinaciones inmunógenas. |
| BR112017026523A2 (pt) | 2015-06-12 | 2018-08-14 | Glaxosmithkline Biologicals Sa | vetor recombinante, adenovírus recombinante, composição, uso de um vetor recombinante, de um adenovírus recombinante ou de uma composição, método para induzir uma resposta imune em um indivíduo, e, polinucleotídeo isolado. |
-
2016
- 2016-06-10 BR BR112017026523A patent/BR112017026523A2/pt not_active IP Right Cessation
- 2016-06-10 JP JP2017564424A patent/JP6983665B2/ja not_active Expired - Fee Related
- 2016-06-10 US US15/735,839 patent/US11254710B2/en active Active
- 2016-06-10 BE BE2016/5434A patent/BE1024420B1/fr active IP Right Grant
- 2016-06-10 WO PCT/EP2016/063329 patent/WO2016198621A1/en not_active Ceased
- 2016-06-10 MX MX2017016101A patent/MX2017016101A/es unknown
- 2016-06-10 KR KR1020187000991A patent/KR20180012857A/ko not_active Ceased
- 2016-06-10 EA EA201792651A patent/EA038402B9/ru unknown
- 2016-06-10 JP JP2017564467A patent/JP6873054B2/ja active Active
- 2016-06-10 KR KR1020177037436A patent/KR102535670B1/ko active Active
- 2016-06-10 CN CN201680047775.1A patent/CN108025058B/zh not_active Expired - Fee Related
- 2016-06-10 EP EP16730315.5A patent/EP3307313A1/en active Pending
- 2016-06-10 AU AU2016275601A patent/AU2016275601A1/en not_active Abandoned
- 2016-06-10 AU AU2016275619A patent/AU2016275619B2/en active Active
- 2016-06-10 CA CA2988654A patent/CA2988654A1/en active Pending
- 2016-06-10 US US15/735,872 patent/US11254711B2/en not_active Expired - Fee Related
- 2016-06-10 EP EP16730773.5A patent/EP3307314A1/en not_active Withdrawn
- 2016-06-10 CN CN201680047373.1A patent/CN107921118B/zh active Active
- 2016-06-10 MX MX2017016105A patent/MX2017016105A/es unknown
- 2016-06-10 WO PCT/EP2016/063297 patent/WO2016198599A1/en not_active Ceased
-
2017
- 2017-12-03 IL IL256069A patent/IL256069B2/en unknown
- 2017-12-05 IL IL256121A patent/IL256121B2/en unknown
-
2019
- 2019-03-26 AU AU2019202081A patent/AU2019202081B2/en active Active
- 2019-11-27 AU AU2019271972A patent/AU2019271972B2/en not_active Ceased
-
2021
- 2021-12-30 US US17/565,796 patent/US20220204566A1/en not_active Abandoned
-
2022
- 2022-01-25 US US17/583,511 patent/US20220220157A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018524977A5 (enExample) | ||
| JP2020511114A5 (enExample) | ||
| JP7274222B2 (ja) | 非ヒト大型類人猿アデノウイルスの核酸配列及びアミノ酸配列、それを含有するベクター、並びにその使用 | |
| JP2018523980A5 (enExample) | ||
| JP2020511940A5 (enExample) | ||
| CN105112428B (zh) | 猿腺病毒核酸和氨基酸序列，包含其的载体及其用途 | |
| CN107921118B (zh) | 腺病毒多核苷酸和多肽 | |
| JP2015057052A5 (enExample) | ||
| JP2012516679A5 (enExample) | ||
| CN110300597A (zh) | 腺病毒多核苷酸和多肽 | |
| EP3655539A1 (en) | Chikungunya virus antigen constructs | |
| CN112638936A (zh) | 腺病毒多核苷酸和多肽 | |
| TWI901715B (zh) | 大猩猩腺病毒核酸及胺基酸序列，包含彼之載體，及其用途 | |
| JP2022547786A5 (enExample) | ||
| HK40031047B (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| HK40031047A (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| US7687615B2 (en) | PAV regions for encapsidation and E1 transcriptional control | |
| NZ759892B2 (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |